Global · Jurisdiction

global regulatory signals

RegSig tracks regulatory developments in global and maps them to your product portfolio. Each signal includes topic classification, time horizon, impact ranking, and evidence context for faster compliance triage.

  • 10 representative signals
  • 6 topics
  • Evidence-linked recommendations

6

Topics

10

Representative signals

global

Jurisdiction

Global

Region

Representative signals in global

Proposed Federal Rule on Additives Labeling Rules for Federal Compliance Timelines

Medium-term

Additives

What changed: Federal regulatory text on this topic was revised, updating labeling, claims, or compliance documentation expectations on affected products.

Multi-source Shift on Nutrition Claims Requirements for Cross-jurisdiction Labels

Near-term

Nutrition Claims

What changed: Front-of-pack and benefit-forwarding display expectations shifted in circulated or final text, constraining how nutrition-related benefits may be highlighted relative to base label disclosures.

Aligned Sources Shift on Front-of-pack Labeling Rules for Multi-source Compliance

Medium-term

Front-of-Pack Labeling

What changed: Front-of-pack and benefit-forwarding display expectations shifted in circulated or final text, constraining how nutrition-related benefits may be highlighted relative to base label disclosures.

FDA Enforcement Focus on Additives Labeling Rules for Marketed Product Labels

Near-term

Additives

What changed: Regulators revised origin-claim and country-of-origin compliance conditions, updating what statements must be substantiated on pack and in supporting records.

FDA Labeling Shift on Country of Origin Labeling Requirements for Federal Labeling

Near-term

Country of Origin

What changed: Regulators revised origin-claim and country-of-origin compliance conditions, updating what statements must be substantiated on pack and in supporting records.

Compliance Enforcement on Health Claims Requirements for Compliance Remediation

Near-term

Health Claims

What changed: Front-of-pack and benefit-forwarding display expectations shifted in circulated or final text, constraining how nutrition-related benefits may be highlighted relative to base label disclosures.

FDA Guidance Proposal on Additives Labeling Rules for FDA-regulated Labels

Near-term

Additives

What changed: Nutrition labeling and point-of-purchase disclosure rules were revised, changing exemption tests and where mandatory nutrition information must appear for consumer products.

FDA Proposed Shift on Additives Labeling Rules for FDA-regulated Labels

Near-term

Additives

What changed: Front-of-pack and benefit-forwarding display expectations shifted in circulated or final text, constraining how nutrition-related benefits may be highlighted relative to base label disclosures.

Federal Register Move on Ingredient Disclosure Requirements for Regulated Product Labels

Medium-term

Ingredient Disclosure

What changed: Front-of-pack and benefit-forwarding display expectations shifted in circulated or final text, constraining how nutrition-related benefits may be highlighted relative to base label disclosures.

FDA Proposed Shift on Health Claims Requirements for FDA-regulated Labels

Near-term

Health Claims

What changed: Front-of-pack and benefit-forwarding display expectations shifted in circulated or final text, constraining how nutrition-related benefits may be highlighted relative to base label disclosures.

Full signal detail and portfolio mapping are available after registration.

Individual access

Monitor global jurisdiction signals in your portfolio

RegSig maps global regulatory signals directly to your product portfolio. Independent practitioners can get started with usage-based billing—pay only for what you run.